Dual inhibition of HER2 in breast cancer treatment

Lancet. 2012 Feb 18;379(9816):596-8. doi: 10.1016/S0140-6736(12)60068-3. Epub 2012 Jan 17.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / antagonists & inhibitors*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Receptor, ErbB-2 / antagonists & inhibitors*

Substances

  • Biomarkers, Tumor
  • Receptor, ErbB-2